A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-Risk Women With Axillary Node-Negative Breast Cancer (NSAS-BC).
Phase of Trial: Phase III
Latest Information Update: 18 May 2016
At a glance
- Drugs Tegafur/uracil (Primary) ; Cyclophosphamide; Fluorouracil; Methotrexate
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2009 Status changed from completed to active, no longer recruiting.
- 09 Feb 2009 Results were published in the Journal of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History